Ligand validation:4KH0

PAL: N-(PHOSPHONACETYL)-L-ASPARTIC ACID

PAL is a Ligand Of Interest in 4KH0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KH0_PAL_C_401	87%	34%	0.107	0.981	1.5	1.21	2	1	0	0	100%	1
4KH0_PAL_A_401	85%	30%	0.123	0.989	1.59	1.34	1	2	0	0	100%	1
4KGX_PAL_A_401	92%	32%	0.098	0.99	1.55	1.26	1	2	0	0	100%	1
1XJW_PAL_C_1312	91%	28%	0.093	0.982	1.18	1.85	1	6	0	0	100%	1
4F04_PAL_C_401	91%	29%	0.1	0.987	1.53	1.42	2	2	0	0	100%	1
1D09_PAL_A_1311	88%	24%	0.099	0.975	1.6	1.66	4	4	0	0	100%	0.99
4KGZ_PAL_C_401	87%	36%	0.101	0.974	1.43	1.19	1	1	0	0	100%	1
6YSP_PAL_C_401	97%	29%	0.069	0.985	1.73	1.26	2	1	0	0	100%	1
6YS6_PAL_C_401	96%	24%	0.075	0.986	1.82	1.44	3	2	0	0	100%	1
6YW9_PAL_A_401	92%	24%	0.086	0.978	2.04	1.24	1	2	0	0	100%	1
1ML4_PAL_A_385	92%	20%	0.086	0.976	1.76	1.8	4	7	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.